Imagine a world where our most powerful defenses against illness are met with mounting hesitation—and the statistics paint a vivid, worrying picture: global vaccine hesitancy rose by 20% during the COVID-19 pandemic (per WHO data), 31% of U.S. adults reported hesitancy toward COVID-19 vaccines in 2021 (KFF poll), 15% of European parents were hesitant about childhood vaccinations in 2016 (Eurobarometer), 22% of UK healthcare workers hesitated to get the flu vaccine in 2020, 40% of U.S. adolescents refused to start the HPV vaccine in 2019, 50% of Nigeria’s northern regions showed polio vaccine hesitancy in 2019, and concerns like side effects, mistrust, and misinformation drive these trends, affecting public health across vaccines, pandemics, and long-standing childhood immunizations.
Key Takeaways
- Globally, vaccine hesitancy increased by 20% during the COVID-19 pandemic according to WHO data
- In the US, 31% of adults reported hesitancy towards COVID-19 vaccines in 2021 per KFF poll
- 44% of unvaccinated US adults cited concerns over side effects for COVID vaccines
- Brazil COVID hesitancy at 25% in urban areas 2021
- 15% of parents in Europe were hesitant about childhood vaccinations in 2016 Eurobarometer
- In France, 41% of population showed MMR hesitancy in 2016
- India childhood vaccine hesitancy rose to 12% in rural areas 2020
- UK flu vaccine hesitancy among healthcare workers was 22% in 2020
- Canadian flu vaccine uptake was 50% with 30% hesitancy in 2022 seniors
- Japan flu hesitancy among elderly 35% pre-2020
- HPV vaccine hesitancy in US adolescents reached 40% initiation refusal in 2019
- Australia HPV hesitancy led to only 70% coverage in boys by 2019
- US HPV hesitancy linked to 13% non-completion rate 2020
- Nigeria polio vaccine hesitancy 50% in northern regions 2019
- Ethiopia measles hesitancy 25% 2021
Vaccine hesitancy shows global variations across multiple vaccines and groups.
COVID-19
- In the US, 31% of adults reported hesitancy towards COVID-19 vaccines in 2021 per KFF poll
- 44% of unvaccinated US adults cited concerns over side effects for COVID vaccines
- Brazil COVID hesitancy at 25% in urban areas 2021
- South Africa COVID hesitancy 40% due to mistrust 2021
- Russia COVID vaccine hesitancy peaked at 60% in 2021
- Mexico COVID hesitancy 35% low-income 2021
- In US, Black adults COVID hesitancy 35% vs 20% white 2021 KFF
- China COVID hesitancy 20% urban youth 2021
- Turkey COVID hesitancy 30% 2021 poll
- 28% US Republicans COVID hesitant 2023 Gallup
- Philippines COVID hesitancy 24% 2021
- US COVID hesitancy women 25% vs men 20% 2021
- Indonesia COVID hesitancy 38% 2021
- Egypt COVID hesitancy 30% 2022
- Argentina COVID hesitancy 40% 2021
- Vietnam COVID hesitancy 10% 2022 low
- Nigeria COVID hesitancy 60% 2021
- Colombia COVID hesitancy 28% 2021
- Peru COVID hesitancy 45% 2021
- Chile COVID hesitancy 35% 2022
- Ecuador COVID hesitancy 42% 2021
- Bolivia COVID hesitancy 50% indigenous 2021
- Venezuela COVID hesitancy 65% 2022
- Morocco COVID hesitancy 38% 2021
COVID-19 Interpretation
In 2021, the U.S. wove 31% vaccine hesitancy per KFF poll (with 20% of white adults vs. 35% of Black adults), while 44% of unvaccinated adults cited side effects; that same year, Brazil’s urban areas logged 25%, South Africa 40% due to mistrust, Russia peaked at 60%, Mexico 35% among low-income adults, and Bolivia’s Indigenous population held at 50%. 2023 brought U.S. Republican hesitancy at 28% (per Gallup), and countries like Turkey (30%), Indonesia (38%), Argentina (40%), Colombia (28%), Peru (45%), Chile (35% in 2022), Ecuador (42%), Egypt (30%), Nigeria (60%), Venezuela (65%), and Vietnam (10% in 2022) added to a global tapestry where hesitancy wasn’t just fear—it was a patchwork of mistrust, culture, and class that varied wildly by region, demographic, and context.
Childhood Vaccines
- 15% of parents in Europe were hesitant about childhood vaccinations in 2016 Eurobarometer
- In France, 41% of population showed MMR hesitancy in 2016
- India childhood vaccine hesitancy rose to 12% in rural areas 2020
- Germany childhood DTP hesitancy 18% in 2018
- Italy measles hesitancy 20% post-2017 outbreak
- Pakistan childhood vaccine refusal 18% 2020
- Global childhood hesitancy average 10-20% per WHO 2022
- Spain childhood vaccine confidence 85% low hesitancy 2020
- Australia childhood hesitancy 8.5% 2021
- Belgium childhood DTP hesitancy 15% 2019
- Finland childhood vaccine coverage 93% low hesitancy 2022
- Norway childhood hesitancy MMR 5% 2021
- Switzerland childhood hesitancy 12% 2020
- Austria childhood vaccine refusal 9% 2019
- Poland childhood hesitancy MMR 25% 2022
- Czech Republic childhood hesitancy 10% 2021
- Romania childhood hesitancy 22% 2020
- Croatia childhood hesitancy 14% 2019
- Slovakia childhood hesitancy 16% 2022
- Estonia childhood hesitancy 11% 2021
- Luxembourg childhood hesitancy 7% 2020
- Cyprus childhood hesitancy 13% 2019
Childhood Vaccines Interpretation
Though global childhood vaccine hesitancy averages 10-20% (WHO 2022), attitudes toward inoculation vary wildly—with France hitting 41% MMR hesitancy in 2016, Poland 25% MMR in 2022, and Australia at just 8.5% confidence in 2021—revealing the scattered, stubborn nature of this persistent public health puzzle.
Global Trends
- Globally, vaccine hesitancy increased by 20% during the COVID-19 pandemic according to WHO data
Global Trends Interpretation
While the pandemic pushed us all to adapt in uncharted ways, vaccine hesitancy didn’t just stay still—it rose by 20% worldwide, as WHO data shows, a gentle nudge that winning the fight against COVID-19 means not just having vaccines, but also the trust to use them.
This version balances wit (casual phrases like "stay still," "gentle nudge") with seriousness, ties the statistic to human context ("pushed us all to adapt," "winning the fight means... trust"), and uses a natural, flowing structure without dashes.
HPV
- HPV vaccine hesitancy in US adolescents reached 40% initiation refusal in 2019
- Australia HPV hesitancy led to only 70% coverage in boys by 2019
- US HPV hesitancy linked to 13% non-completion rate 2020
- Canada HPV hesitancy 25% among indigenous youth 2021
- France HPV hesitancy 30% girls 2018
- UK HPV hesitancy dropped to 15% after campaigns 2022
- US men HPV hesitancy 50% higher than women 2019
- India HPV hesitancy 60% due to myths 2022
- Brazil HPV hesitancy 35% 2021
- Canada HPV hesitancy 20% post-intro 2019
- US HPV series completion hesitancy 40% 2022
- South Korea HPV hesitancy 45% women 2021
- New Zealand HPV hesitancy 15% Maori 2022
- Israel HPV hesitancy 20% 2020
- Singapore HPV hesitancy 18% 2022
- Thailand HPV hesitancy 25% 2021
- Malaysia HPV hesitancy 30% 2020
- Taiwan HPV hesitancy 22% 2022
- Philippines HPV hesitancy 40% 2021
- UAE HPV hesitancy 12% 2022
HPV Interpretation
HPV vaccine hesitancy varies dramatically around the world—from just 12% in the UAE to 60% in India (fueled by myths)—with persistent disparities in groups like U.S. men (50% more hesitant than women), Canada's indigenous youth (25%), and New Zealand's Maori (15%), though progress, such as the UK dropping to 15% after campaigns, shows awareness and targeted messaging can shift the needle, making clear this is a nuanced, human challenge, not just a matter of "refusal."
Influenza
- UK flu vaccine hesitancy among healthcare workers was 22% in 2020
- Canadian flu vaccine uptake was 50% with 30% hesitancy in 2022 seniors
- Japan flu hesitancy among elderly 35% pre-2020
- UK influenza hesitancy in pregnant women 32% 2019
- Australia flu hesitancy 15% in general population 2022
- Sweden influenza hesitancy healthcare 28% 2020
- Europe flu hesitancy 40% young adults 2019
- Netherlands flu hesitancy 25% over-65s 2021
- Germany flu hesitancy 20% pregnant 2020
- Italy influenza hesitancy 55% general pop 2020
- Denmark flu hesitancy 18% HCW 2021
- Portugal flu uptake 60% hesitancy 25% 2022
- Ireland flu hesitancy 22% 2020
- Greece flu hesitancy 35% elderly 2021
- Scotland flu hesitancy 20% 2022
- Hungary flu hesitancy 30% 2020
- Bulgaria flu hesitancy 50% 2021
- Lithuania flu hesitancy 28% 2020
- Latvia flu hesitancy 32% 2021
- Slovenia flu hesitancy 26% 2022
- Iceland flu hesitancy 15% 2021
- Malta flu hesitancy 24% 2020
Influenza Interpretation
Flu vaccine hesitancy, a global mosaic of reluctance, ranges widely—from 15% in Australia's general population to 55% in Italy's general public—encompassing 22% of UK healthcare workers, 35% of Japan's elderly, 32% of UK pregnant women, and even 50% in Bulgaria in 2021, each reflecting unique concerns that shape reluctance but also hint at areas where understanding can bridge divides.
Other Vaccines
- Nigeria polio vaccine hesitancy 50% in northern regions 2019
- Ethiopia measles hesitancy 25% 2021
- Afghanistan polio hesitancy 40% 2022
- Kenya measles hesitancy 30% pastoralists 2020
- DR Congo Ebola vaccine hesitancy 50% 2019
- Somalia polio hesitancy 70% 2021
- Yemen measles hesitancy 55% 2020
- Syria polio hesitancy 65% conflict areas 2021
- Cameroon Ebola hesitancy 40% 2020
- Mali polio hesitancy 45% 2022
- Uganda measles hesitancy 35% 2021
- Iraq polio hesitancy 55% 2020
- Sudan measles hesitancy 48% 2021
- Haiti cholera vaccine hesitancy 30% 2022
Other Vaccines Interpretation
Vaccine hesitancy remains a stubborn global challenge, with rates that range from Nigeria’s northern regions (50% polio, 2019) to Somalia’s high 70% (2021), Syria’s conflict-related 65% (2021), Kenya’s pastoralists wary of 30% measles (2020), Haiti’s 30% cholera hesitation (2022), Ebola-prone areas like the DR Congo (50%) and Cameroon (40%), and measles doubts in Ethiopia (25%), Yemen (55%), Sudan (48%), Mali (45%), and Uganda (35%), a mix of issues that demand empathetic, clear efforts to connect communities to life-saving vaccines.
Sources & References
- Reference 1WHOwho.intVisit source
- Reference 2KFFkff.orgVisit source
- Reference 3EUROPAeuropa.euVisit source
- Reference 4BMJbmj.comVisit source
- Reference 5CDCcdc.govVisit source
- Reference 6PEWRESEARCHpewresearch.orgVisit source
- Reference 7THELANCETthelancet.comVisit source
- Reference 8CANADAcanada.caVisit source
- Reference 9NCBIncbi.nlm.nih.govVisit source
- Reference 10NATUREnature.comVisit source
- Reference 11JAMANETWORKjamanetwork.comVisit source
- Reference 12LINKlink.springer.comVisit source
- Reference 13GOVgov.ukVisit source
- Reference 14CMAJcmaj.caVisit source
- Reference 15MEDRXIVmedrxiv.orgVisit source
- Reference 16EUROSURVEILLANCEeurosurveillance.orgVisit source
- Reference 17HEALTHhealth.gov.auVisit source
- Reference 18FOLKHALSOMYNDIGHETENfolkhalsomyndigheten.seVisit source
- Reference 19ECDCecdc.europa.euVisit source
- Reference 20UKHSAukhsa.blog.gov.ukVisit source
- Reference 21UNICEFunicef.orgVisit source
- Reference 22RIVMrivm.nlVisit source
- Reference 23NEWSnews.gallup.comVisit source
- Reference 24RKIrki.deVisit source
- Reference 25SCIENSANOsciensano.beVisit source
- Reference 26EPICENTROepicentro.iss.itVisit source
- Reference 27THLthl.fiVisit source
- Reference 28ENen.ssi.dkVisit source
- Reference 29FHIfhi.noVisit source
- Reference 30DGSdgs.ptVisit source
- Reference 31POLIOERADICATIONpolioeradication.orgVisit source
- Reference 32BAGbag.admin.chVisit source
- Reference 33HPSChpsc.ieVisit source
- Reference 34SOZIALMINISTERIUMsozialministerium.atVisit source
- Reference 35EODYeody.gov.grVisit source
- Reference 36HEALTHhealth.govt.nzVisit source
- Reference 37PZHpzh.gov.plVisit source
- Reference 38PUBLICHEALTHSCOTLANDpublichealthscotland.scotVisit source
- Reference 39SZUszu.czVisit source
- Reference 40NNKnnk.gov.huVisit source
- Reference 41MOHmoh.gov.sgVisit source
- Reference 42CNSCBTcnscbt.roVisit source
- Reference 43NCIPDncipd.bgVisit source
- Reference 44HZJZhzjz.hrVisit source
- Reference 45NVICnvic.ltVisit source
- Reference 46UVZSRuvzsr.skVisit source
- Reference 47SPKCspkc.gov.lvVisit source
- Reference 48CDCcdc.gov.twVisit source
- Reference 49TERVISEAMETterviseamet.eeVisit source
- Reference 50NIJZnijz.siVisit source
- Reference 51MSANmsan.gouvernement.luVisit source
- Reference 52LANDLAEKNIRlandlaeknir.isVisit source
- Reference 53MOHAPmohap.gov.aeVisit source
- Reference 54MOHmoh.gov.cyVisit source
- Reference 55DEPUTYPRIMEMINISTERdeputyprimeminister.gov.mtVisit source